0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-LVP Parenterals Products Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-23P2721
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non LVP Parenterals Products Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-LVP Parenterals Products Market Insights, Forecast to 2030

Code: QYRE-Auto-23P2721
Report
December 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-LVP Parenterals Products Market

Non-LVP parenterals products referred to the small volume parenteral except biologicals. Small volume parenteral solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Non-LVP Parenterals Products market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Non-LVP Parenterals Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Non-LVP Parenterals Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Non-LVP Parenterals Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Non-LVP Parenterals Products include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Non-LVP Parenterals Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Non-LVP Parenterals Products, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-LVP Parenterals Products, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-LVP Parenterals Products sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Non-LVP Parenterals Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Non-LVP Parenterals Products sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Non-LVP Parenterals Products Market Report

Report Metric Details
Report Name Non-LVP Parenterals Products Market
Segment by Type
  • Ampules
  • Vials
  • Prefilled Syringes
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, J&J, Pfizer, Teva, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Non-LVP Parenterals Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Non-LVP Parenterals Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-LVP Parenterals Products sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-LVP Parenterals Products Market report?

Ans: The main players in the Non-LVP Parenterals Products Market are GSK, J&J, Pfizer, Teva, Novartis

What are the Application segmentation covered in the Non-LVP Parenterals Products Market report?

Ans: The Applications covered in the Non-LVP Parenterals Products Market report are Local Anesthetics, Vaccines, Other

What are the Type segmentation covered in the Non-LVP Parenterals Products Market report?

Ans: The Types covered in the Non-LVP Parenterals Products Market report are Ampules, Vials, Prefilled Syringes

Recommended Reports

Parenteral Packaging

Non-PVC Medical Products

Parenteral Nutrition & Consumables

1 Study Coverage
1.1 Non-LVP Parenterals Products Product Introduction
1.2 Market by Type
1.2.1 Global Non-LVP Parenterals Products Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Market by Application
1.3.1 Global Non-LVP Parenterals Products Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-LVP Parenterals Products Sales Estimates and Forecasts 2019-2030
2.2 Global Non-LVP Parenterals Products Revenue by Region
2.2.1 Global Non-LVP Parenterals Products Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Non-LVP Parenterals Products Revenue by Region (2019-2024)
2.2.3 Global Non-LVP Parenterals Products Revenue by Region (2025-2030)
2.2.4 Global Non-LVP Parenterals Products Revenue Market Share by Region (2019-2030)
2.3 Global Non-LVP Parenterals Products Sales Estimates and Forecasts 2019-2030
2.4 Global Non-LVP Parenterals Products Sales by Region
2.4.1 Global Non-LVP Parenterals Products Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Non-LVP Parenterals Products Sales by Region (2019-2024)
2.4.3 Global Non-LVP Parenterals Products Sales by Region (2025-2030)
2.4.4 Global Non-LVP Parenterals Products Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Non-LVP Parenterals Products Sales by Manufacturers
3.1.1 Global Non-LVP Parenterals Products Sales by Manufacturers (2019-2024)
3.1.2 Global Non-LVP Parenterals Products Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-LVP Parenterals Products in 2023
3.2 Global Non-LVP Parenterals Products Revenue by Manufacturers
3.2.1 Global Non-LVP Parenterals Products Revenue by Manufacturers (2019-2024)
3.2.2 Global Non-LVP Parenterals Products Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Non-LVP Parenterals Products Revenue in 2023
3.3 Global Key Players of Non-LVP Parenterals Products, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Non-LVP Parenterals Products Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Non-LVP Parenterals Products, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Non-LVP Parenterals Products, Product Offered and Application
3.8 Global Key Manufacturers of Non-LVP Parenterals Products, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-LVP Parenterals Products Sales by Type
4.1.1 Global Non-LVP Parenterals Products Historical Sales by Type (2019-2024)
4.1.2 Global Non-LVP Parenterals Products Forecasted Sales by Type (2025-2030)
4.1.3 Global Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
4.2 Global Non-LVP Parenterals Products Revenue by Type
4.2.1 Global Non-LVP Parenterals Products Historical Revenue by Type (2019-2024)
4.2.2 Global Non-LVP Parenterals Products Forecasted Revenue by Type (2025-2030)
4.2.3 Global Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
4.3 Global Non-LVP Parenterals Products Price by Type
4.3.1 Global Non-LVP Parenterals Products Price by Type (2019-2024)
4.3.2 Global Non-LVP Parenterals Products Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Non-LVP Parenterals Products Sales by Application
5.1.1 Global Non-LVP Parenterals Products Historical Sales by Application (2019-2024)
5.1.2 Global Non-LVP Parenterals Products Forecasted Sales by Application (2025-2030)
5.1.3 Global Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
5.2 Global Non-LVP Parenterals Products Revenue by Application
5.2.1 Global Non-LVP Parenterals Products Historical Revenue by Application (2019-2024)
5.2.2 Global Non-LVP Parenterals Products Forecasted Revenue by Application (2025-2030)
5.2.3 Global Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
5.3 Global Non-LVP Parenterals Products Price by Application
5.3.1 Global Non-LVP Parenterals Products Price by Application (2019-2024)
5.3.2 Global Non-LVP Parenterals Products Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Non-LVP Parenterals Products Market Size by Type
6.1.1 US & Canada Non-LVP Parenterals Products Sales by Type (2019-2030)
6.1.2 US & Canada Non-LVP Parenterals Products Revenue by Type (2019-2030)
6.2 US & Canada Non-LVP Parenterals Products Market Size by Application
6.2.1 US & Canada Non-LVP Parenterals Products Sales by Application (2019-2030)
6.2.2 US & Canada Non-LVP Parenterals Products Revenue by Application (2019-2030)
6.3 US & Canada Non-LVP Parenterals Products Market Size by Country
6.3.1 US & Canada Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Non-LVP Parenterals Products Sales by Country (2019-2030)
6.3.3 US & Canada Non-LVP Parenterals Products Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Non-LVP Parenterals Products Market Size by Type
7.1.1 Europe Non-LVP Parenterals Products Sales by Type (2019-2030)
7.1.2 Europe Non-LVP Parenterals Products Revenue by Type (2019-2030)
7.2 Europe Non-LVP Parenterals Products Market Size by Application
7.2.1 Europe Non-LVP Parenterals Products Sales by Application (2019-2030)
7.2.2 Europe Non-LVP Parenterals Products Revenue by Application (2019-2030)
7.3 Europe Non-LVP Parenterals Products Market Size by Country
7.3.1 Europe Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Non-LVP Parenterals Products Sales by Country (2019-2030)
7.3.3 Europe Non-LVP Parenterals Products Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Non-LVP Parenterals Products Market Size
8.1.1 China Non-LVP Parenterals Products Sales (2019-2030)
8.1.2 China Non-LVP Parenterals Products Revenue (2019-2030)
8.2 China Non-LVP Parenterals Products Market Size by Application
8.2.1 China Non-LVP Parenterals Products Sales by Application (2019-2030)
8.2.2 China Non-LVP Parenterals Products Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Non-LVP Parenterals Products Market Size by Type
9.1.1 Asia Non-LVP Parenterals Products Sales by Type (2019-2030)
9.1.2 Asia Non-LVP Parenterals Products Revenue by Type (2019-2030)
9.2 Asia Non-LVP Parenterals Products Market Size by Application
9.2.1 Asia Non-LVP Parenterals Products Sales by Application (2019-2030)
9.2.2 Asia Non-LVP Parenterals Products Revenue by Application (2019-2030)
9.3 Asia Non-LVP Parenterals Products Sales by Region
9.3.1 Asia Non-LVP Parenterals Products Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Non-LVP Parenterals Products Revenue by Region (2019-2030)
9.3.3 Asia Non-LVP Parenterals Products Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Non-LVP Parenterals Products Market Size by Type
10.1.1 Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Non-LVP Parenterals Products Market Size by Application
10.2.1 Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Country
10.3.1 Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Overview
11.1.3 Allergan Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Allergan Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 GSK Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 J&J
11.4.1 J&J Company Information
11.4.2 J&J Overview
11.4.3 J&J Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 J&J Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 J&J Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pfizer Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Overview
11.6.3 Teva Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Teva Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Non-LVP Parenterals Products Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Novartis Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-LVP Parenterals Products Industry Chain Analysis
12.2 Non-LVP Parenterals Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-LVP Parenterals Products Production Mode & Process
12.4 Non-LVP Parenterals Products Sales and Marketing
12.4.1 Non-LVP Parenterals Products Sales Channels
12.4.2 Non-LVP Parenterals Products Distributors
12.5 Non-LVP Parenterals Products Customers
13 Market Dynamics
13.1 Non-LVP Parenterals Products Industry Trends
13.2 Non-LVP Parenterals Products Market Drivers
13.3 Non-LVP Parenterals Products Market Challenges
13.4 Non-LVP Parenterals Products Market Restraints
14 Key Findings in The Global Non-LVP Parenterals Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Non-LVP Parenterals Products Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Ampules
    Table 3. Major Manufacturers of Vials
    Table 4. Major Manufacturers of Prefilled Syringes
    Table 5. Global Non-LVP Parenterals Products Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Non-LVP Parenterals Products Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Non-LVP Parenterals Products Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Non-LVP Parenterals Products Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Non-LVP Parenterals Products Revenue Market Share by Region (2019-2024)
    Table 10. Global Non-LVP Parenterals Products Revenue Market Share by Region (2025-2030)
    Table 11. Global Non-LVP Parenterals Products Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Non-LVP Parenterals Products Sales by Region (2019-2024) & (K Doses)
    Table 13. Global Non-LVP Parenterals Products Sales by Region (2025-2030) & (K Doses)
    Table 14. Global Non-LVP Parenterals Products Sales Market Share by Region (2019-2024)
    Table 15. Global Non-LVP Parenterals Products Sales Market Share by Region (2025-2030)
    Table 16. Global Non-LVP Parenterals Products Sales by Manufacturers (2019-2024) & (K Doses)
    Table 17. Global Non-LVP Parenterals Products Sales Share by Manufacturers (2019-2024)
    Table 18. Global Non-LVP Parenterals Products Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Non-LVP Parenterals Products Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Non-LVP Parenterals Products, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Non-LVP Parenterals Products Price by Manufacturers 2019-2024 (USD/Dose)
    Table 22. Global Non-LVP Parenterals Products Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Non-LVP Parenterals Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-LVP Parenterals Products as of 2023)
    Table 24. Global Key Manufacturers of Non-LVP Parenterals Products, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Non-LVP Parenterals Products, Product Offered and Application
    Table 26. Global Key Manufacturers of Non-LVP Parenterals Products, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Non-LVP Parenterals Products Sales by Type (2019-2024) & (K Doses)
    Table 29. Global Non-LVP Parenterals Products Sales by Type (2025-2030) & (K Doses)
    Table 30. Global Non-LVP Parenterals Products Sales Share by Type (2019-2024)
    Table 31. Global Non-LVP Parenterals Products Sales Share by Type (2025-2030)
    Table 32. Global Non-LVP Parenterals Products Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Non-LVP Parenterals Products Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Non-LVP Parenterals Products Revenue Share by Type (2019-2024)
    Table 35. Global Non-LVP Parenterals Products Revenue Share by Type (2025-2030)
    Table 36. Non-LVP Parenterals Products Price by Type (2019-2024) & (USD/Dose)
    Table 37. Global Non-LVP Parenterals Products Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 38. Global Non-LVP Parenterals Products Sales by Application (2019-2024) & (K Doses)
    Table 39. Global Non-LVP Parenterals Products Sales by Application (2025-2030) & (K Doses)
    Table 40. Global Non-LVP Parenterals Products Sales Share by Application (2019-2024)
    Table 41. Global Non-LVP Parenterals Products Sales Share by Application (2025-2030)
    Table 42. Global Non-LVP Parenterals Products Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Non-LVP Parenterals Products Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Non-LVP Parenterals Products Revenue Share by Application (2019-2024)
    Table 45. Global Non-LVP Parenterals Products Revenue Share by Application (2025-2030)
    Table 46. Non-LVP Parenterals Products Price by Application (2019-2024) & (USD/Dose)
    Table 47. Global Non-LVP Parenterals Products Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 48. US & Canada Non-LVP Parenterals Products Sales by Type (2019-2024) & (K Doses)
    Table 49. US & Canada Non-LVP Parenterals Products Sales by Type (2025-2030) & (K Doses)
    Table 50. US & Canada Non-LVP Parenterals Products Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Non-LVP Parenterals Products Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Non-LVP Parenterals Products Sales by Application (2019-2024) & (K Doses)
    Table 53. US & Canada Non-LVP Parenterals Products Sales by Application (2025-2030) & (K Doses)
    Table 54. US & Canada Non-LVP Parenterals Products Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Non-LVP Parenterals Products Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Non-LVP Parenterals Products Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 60. US & Canada Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 61. Europe Non-LVP Parenterals Products Sales by Type (2019-2024) & (K Doses)
    Table 62. Europe Non-LVP Parenterals Products Sales by Type (2025-2030) & (K Doses)
    Table 63. Europe Non-LVP Parenterals Products Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Non-LVP Parenterals Products Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Non-LVP Parenterals Products Sales by Application (2019-2024) & (K Doses)
    Table 66. Europe Non-LVP Parenterals Products Sales by Application (2025-2030) & (K Doses)
    Table 67. Europe Non-LVP Parenterals Products Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Non-LVP Parenterals Products Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Non-LVP Parenterals Products Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 73. Europe Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 74. China Non-LVP Parenterals Products Sales by Type (2019-2024) & (K Doses)
    Table 75. China Non-LVP Parenterals Products Sales by Type (2025-2030) & (K Doses)
    Table 76. China Non-LVP Parenterals Products Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Non-LVP Parenterals Products Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Non-LVP Parenterals Products Sales by Application (2019-2024) & (K Doses)
    Table 79. China Non-LVP Parenterals Products Sales by Application (2025-2030) & (K Doses)
    Table 80. China Non-LVP Parenterals Products Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Non-LVP Parenterals Products Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Non-LVP Parenterals Products Sales by Type (2019-2024) & (K Doses)
    Table 83. Asia Non-LVP Parenterals Products Sales by Type (2025-2030) & (K Doses)
    Table 84. Asia Non-LVP Parenterals Products Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Non-LVP Parenterals Products Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Non-LVP Parenterals Products Sales by Application (2019-2024) & (K Doses)
    Table 87. Asia Non-LVP Parenterals Products Sales by Application (2025-2030) & (K Doses)
    Table 88. Asia Non-LVP Parenterals Products Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Non-LVP Parenterals Products Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Non-LVP Parenterals Products Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Non-LVP Parenterals Products Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Non-LVP Parenterals Products Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Non-LVP Parenterals Products Sales by Region (2019-2024) & (K Doses)
    Table 94. Asia Non-LVP Parenterals Products Sales by Region (2025-2030) & (K Doses)
    Table 95. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Type (2019-2024) & (K Doses)
    Table 96. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Type (2025-2030) & (K Doses)
    Table 97. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Application (2019-2024) & (K Doses)
    Table 100. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Application (2025-2030) & (K Doses)
    Table 101. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Country (2019-2024) & (K Doses)
    Table 107. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales by Country (2025-2030) & (K Doses)
    Table 108. Allergan Company Information
    Table 109. Allergan Description and Major Businesses
    Table 110. Allergan Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 111. Allergan Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Allergan Recent Developments
    Table 113. Bayer Company Information
    Table 114. Bayer Description and Major Businesses
    Table 115. Bayer Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 116. Bayer Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bayer Recent Developments
    Table 118. GSK Company Information
    Table 119. GSK Description and Major Businesses
    Table 120. GSK Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 121. GSK Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. GSK Recent Developments
    Table 123. J&J Company Information
    Table 124. J&J Description and Major Businesses
    Table 125. J&J Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 126. J&J Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. J&J Recent Developments
    Table 128. Pfizer Company Information
    Table 129. Pfizer Description and Major Businesses
    Table 130. Pfizer Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 131. Pfizer Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Pfizer Recent Developments
    Table 133. Teva Company Information
    Table 134. Teva Description and Major Businesses
    Table 135. Teva Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 136. Teva Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Teva Recent Developments
    Table 138. Novartis Company Information
    Table 139. Novartis Description and Major Businesses
    Table 140. Novartis Non-LVP Parenterals Products Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 141. Novartis Non-LVP Parenterals Products Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Novartis Recent Developments
    Table 143. Key Raw Materials Lists
    Table 144. Raw Materials Key Suppliers Lists
    Table 145. Non-LVP Parenterals Products Distributors List
    Table 146. Non-LVP Parenterals Products Customers List
    Table 147. Non-LVP Parenterals Products Market Trends
    Table 148. Non-LVP Parenterals Products Market Drivers
    Table 149. Non-LVP Parenterals Products Market Challenges
    Table 150. Non-LVP Parenterals Products Market Restraints
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-LVP Parenterals Products Product Picture
    Figure 2. Global Non-LVP Parenterals Products Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Non-LVP Parenterals Products Market Share by Type in 2023 & 2030
    Figure 4. Ampules Product Picture
    Figure 5. Vials Product Picture
    Figure 6. Prefilled Syringes Product Picture
    Figure 7. Global Non-LVP Parenterals Products Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Non-LVP Parenterals Products Market Share by Application in 2023 & 2030
    Figure 9. Local Anesthetics
    Figure 10. Vaccines
    Figure 11. Other
    Figure 12. Non-LVP Parenterals Products Report Years Considered
    Figure 13. Global Non-LVP Parenterals Products Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Non-LVP Parenterals Products Revenue 2019-2030 (US$ Million)
    Figure 15. Global Non-LVP Parenterals Products Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Non-LVP Parenterals Products Revenue Market Share by Region (2019-2030)
    Figure 17. Global Non-LVP Parenterals Products Sales 2019-2030 ((K Doses)
    Figure 18. Global Non-LVP Parenterals Products Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Non-LVP Parenterals Products Sales YoY (2019-2030) & (K Doses)
    Figure 20. US & Canada Non-LVP Parenterals Products Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Non-LVP Parenterals Products Sales YoY (2019-2030) & (K Doses)
    Figure 22. Europe Non-LVP Parenterals Products Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Non-LVP Parenterals Products Sales YoY (2019-2030) & (K Doses)
    Figure 24. China Non-LVP Parenterals Products Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Non-LVP Parenterals Products Sales YoY (2019-2030) & (K Doses)
    Figure 26. Asia (excluding China) Non-LVP Parenterals Products Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales YoY (2019-2030) & (K Doses)
    Figure 28. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Non-LVP Parenterals Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Non-LVP Parenterals Products in the World: Market Share by Non-LVP Parenterals Products Revenue in 2023
    Figure 31. Global Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
    Figure 33. Global Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
    Figure 34. Global Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
    Figure 35. Global Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Non-LVP Parenterals Products Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Non-LVP Parenterals Products Sales Share by Country (2019-2030)
    Figure 42. U.S. Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
    Figure 45. Europe Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
    Figure 47. Europe Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Non-LVP Parenterals Products Revenue Share by Country (2019-2030)
    Figure 49. Europe Non-LVP Parenterals Products Sales Share by Country (2019-2030)
    Figure 50. Germany Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 51. France Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 55. China Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
    Figure 56. China Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
    Figure 57. China Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
    Figure 58. China Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
    Figure 60. Asia Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
    Figure 62. Asia Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Non-LVP Parenterals Products Revenue Share by Region (2019-2030)
    Figure 64. Asia Non-LVP Parenterals Products Sales Share by Region (2019-2030)
    Figure 65. Japan Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 69. India Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Non-LVP Parenterals Products Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Non-LVP Parenterals Products Sales Share by Country (2019-2030)
    Figure 76. Brazil Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Non-LVP Parenterals Products Revenue (2019-2030) & (US$ Million)
    Figure 81. Non-LVP Parenterals Products Value Chain
    Figure 82. Non-LVP Parenterals Products Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart